Radiation Therapy Oncology Group

This study tested whether adding short-term hormone therapy to high-dose radiation helps men with intermediate-risk prostate cancer live longer. Over 1,500 men participated, and the results showed that the combination improved survival rates. The treatment aims to control the dis…

This study tested whether adding a drug called TAK-700 to standard hormone therapy and radiation could better control high-risk prostate cancer. About 239 men participated. The goal was to see if the stronger hormone combo delayed cancer recurrence, but patients still need ongoin…

This study looked at 236 women with high-risk early-stage cervical cancer who had already had surgery. They all received chemotherapy and radiation, and half also got extra chemo afterward. The goal was to see if the extra chemo helped keep the cancer from coming back. The result…

This study looked at 588 men with intermediate-risk prostate cancer to see if adding external beam radiation to brachytherapy (placing radioactive seeds directly into the tumor) works better than brachytherapy alone. The goal was to control the cancer and prevent it from coming b…

This study tested whether proton radiation therapy combined with chemotherapy helps people with inoperable stage II-IIIB non-small cell lung cancer live longer compared to standard photon radiation therapy. About 330 adults took part. The goal was to see which approach better con…

This study tested whether adding a precise, high-dose radiation treatment (SBRT) to the standard drug sorafenib helps people with advanced liver cancer live longer compared to taking sorafenib alone. About 193 adults with liver cancer that could not be surgically removed took par…

This large phase III trial studied nearly 1,000 people with HPV-related oropharynx (throat) cancer. It compared radiation therapy combined with the targeted drug cetuximab versus standard chemoradiotherapy (radiation plus cisplatin). The goal was to see which approach works bette…